← Health care and life sciences companies

    ADmit Therapeutics: company profile, size and contacts

    admit-therapeutics.comActiveFor profit

    ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.

    Employees
    1-10
    Founded
    2017
    Total raised
    $8M
    Monthly visits
    67

    Company facts

    Website
    admit-therapeutics.com
    Location
    European Union (EU), Europe, Middle East, and Africa (EMEA)
    Employees
    1-10
    Founded
    2017 (9 years ago)
    Categories
    Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
    Company type
    For profit
    Listing
    Private
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founder

    • Marta BarrachinaFounder · ADmit Therapeutics

    ADmit Therapeutics was founded in 2017 by Marta Barrachina.

    Funding

    Total raised
    $8M
    Funding rounds
    5
    Latest round
    Series unknown, 2023-07
    Investors
    7
    Lead investors
    3

    Web and app presence

    Monthly website visits
    67
    Global traffic rank
    #13,993,270

    How ADmit Therapeutics compares

    • Size: ADmit Therapeutics has more employees than 0% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: ADmit Therapeutics is older than 11% of the 1166 health care and life sciences companies in our directory that report it.
    • Web traffic: ADmit Therapeutics gets more monthly website visits than 1% of the 1233 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 186 of them in the same 1-10 employee range and 184 based in European Union (EU).

    Growth outlook

    • Trend: Growing
    • Direction: Growing
    • Confidence: High

    ADmit Therapeutics may be growing as it has successfully secured 5.4 million euros in a funding round. This capital injection indicates investor confidence and provides the financial resources necessary for further development and expansion. The company's ability to attract such funding suggests a positive trajectory in its operations within the biotechnology and health diagnostics industry.

    What ADmit Therapeutics says about itself

    “ADmit THERAPEUTICS - un test de diagnóstico precoz para la enfermedad de Alzheimer. DETECCIÓN EN LA PRÁCTICA CLÍNICA. ADmit Therapeutics, S.L.” admit-therapeutics.com

    ADmit Therapeutics in short

    Founded in 2017, ADmit Therapeutics works in biotechnology, health care and health diagnostics from European Union (EU) and has 1-10 employees. It has raised $8 million over 5 rounds and its website drew about 67 visits in the latest month measured.

    Frequently asked questions

    What does ADmit Therapeutics do?
    ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.
    When was ADmit Therapeutics founded?
    ADmit Therapeutics was founded in 2017, so it is about 9 years old.
    How many employees does ADmit Therapeutics have?
    Crunchbase lists ADmit Therapeutics in the 1-10 employee range.
    Where is ADmit Therapeutics based?
    ADmit Therapeutics is listed under European Union (EU), Europe, Middle East, and Africa (EMEA).
    Has ADmit Therapeutics raised funding?
    Crunchbase records $8M raised across 5 funding rounds, most recently series unknown in 2023-07.
    How do I find email addresses at ADmit Therapeutics?
    Search the domain admit-therapeutics.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.